← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
261 ta ish
Ish: Checkpoint inhibition and beyond: Precision immune engineering for the immune-privileged landscape of ocular malignancies
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott +26
Maqola20109 iqtibosABICAR-T cell therapy for cancer: current challenges and future directions
Inés Zugasti, Lady Espinosa-Aroca, Klaudyna Fidyt +7
Sharh maqola20254 iqtibosABIComputational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
Saber İmani, Xiaoyan Li, Xiaoyan Li +7
Sharh maqola20253 iqtibosABIThe Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain, Renier J. Brentjens, Isabelle Rivière
Sharh maqola20133 iqtibosABIEngineering and Design of Chimeric Antigen Receptors
Sònia Guedan, Hugo Calderón, Avery D. Posey +1
Sharh maqola20183 iqtibosABIGene regulation by non-Coding RNAs in infertility: a mechanistic review
AmirHossien Borji, Cena Aram, Fatemeh Ziyadloo +6
Maqola20253 iqtibosABIT cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce, Douglas T. Fearon
Sharh maqola20152 iqtibosABINivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
Caroline Robert, Georgina V. Long, Benjamin Brady +25
Maqola20142 iqtibosABIDevelopment of new therapeutic options for the treatment of uveal melanoma
Janney Z. Wang, Vivian Lin, Elsa Toumi +8
Sharh maqola20212 iqtibosABIEditorial: Advancements in multi-omics and bioinformatics for the management of solid malignancies
Noha Mousaad Elemam, Pengpeng Zhang, Wantao Wu +3
Tahririyat maqolasi20252 iqtibosABIThe Natural Cytotoxicity Receptors in Health and Disease
Alexander D. Barrow, Claudia Martín, Marco Colonna
Sharh maqola20192 iqtibosABI